Pfizer Inc.
US ˙ NYSE ˙ US7170811035

SecurityPFE / Pfizer Inc.
InstitutionTri-continental Corp
Latest Disclosed Ownership200,000 shares
Latest Disclosed Value $ 4,848,000
Tri-continental Corp reports 5.26% increase in ownership of PFE / Pfizer Inc.

On August 22, 2025 - Tri-continental Corp filed a NPORT-P form disclosing ownership of 200,000 shares of Pfizer Inc. (US:PFE) valued at $4,848,000 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 27, 2025 disclosing 190,000 shares of Pfizer Inc.. This represents a change in shares of 5.26% during the quarter. The current value of the position is $5,068,000 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-22 2025-06-30 NP Pfizer EC US7170811035 200,000 10,000 5.26 4,848 0.71 0.2601
2025-05-27 2025-03-31 NP Pfizer EC US7170811035 190,000 -85,000 -30.91 4,815 -34.01 0.2693
2025-02-28 2024-12-31 NP Pfizer EC US7170811035 275,000 25,000 10.00 7,296 0.83 0.3914
2024-11-25 2024-09-30 NP Pfizer EC US7170811035 250,000 0 0.00 7,235 3.43 0.3775
2024-08-27 2024-06-30 NP Pfizer EC US7170811035 250,000 0 0.00 6,995 0.84 0.3842
2024-05-28 2024-03-31 NP Pfizer EC US7170811035 250,000 110,000 78.57 6,938 72.13 0.3809
2024-02-26 2023-12-31 NP Pfizer EC US7170811035 140,000 -142,391 -50.42 4,031 -56.97 0.2355
2023-11-27 2023-09-30 NP Pfizer EC US7170811035 282,391 -273,079 -49.16 9,367 -54.03 0.5837
2023-08-24 2023-06-30 NP Pfizer EC US7170811035 555,470 -27,134 -4.66 20,375 -14.29 1.2254
2023-05-25 2023-03-31 NP Pfizer EC US7170811035 582,604 -9,428 -1.59 23,770 -21.64 1.4646
2023-02-24 2022-12-31 NP Pfizer EC US7170811035 592,032 1,984 0.34 30,336 17.49 1.9231
2022-11-25 2022-09-30 NP Pfizer EC US7170811035 590,048 -20,801 -3.41 25,820 -19.38 1.7033
2022-08-24 2022-06-30 NP Pfizer EC US7170811035 610,849 -30,718 -4.79 32,027 -3.57 1.9784
2022-05-25 2022-03-31 NP Pfizer EC US7170811035 641,567 -48,874 -7.08 33,214 -18.54 1.7329
2022-02-24 2021-12-31 NP Pfizer EC US7170811035 690,441 -20,016 -2.82 40,771 33.43 2.0325
2021-11-23 2021-09-30 NP Pfizer EC US7170811035 710,457 148,757 26.48 30,557 38.92 1.5707
2021-08-25 2021-06-30 NP Pfizer EC US7170811035 561,700 0 0.00 21,996 8.09 1.1173
2021-05-25 2021-03-31 NP Pfizer EC US7170811035 561,700 456,700 434.95 20,350 428.16 1.0851
2020-11-24 2020-09-30 NP Pfizer EC US7170811035 105,000 -5,000 -4.55 3,854 7.12 0.2439
2020-08-26 2020-06-30 NP Pfizer EC US7170811035 110,000 -5,000 -4.35 3,597 -4.16 0.2383
2020-05-28 2020-03-31 NP Pfizer EC US7170811035 115,000 0 0.00 3,754 -16.69 0.2903
2020-02-25 2019-12-31 NP Pfizer EC 717081103 115,000 10,000 9.52 4,506 19.43 0.2706
2019-11-26 2019-09-30 NP Pfizer EC US7170811035 105,000 105,000 3,773 0.2378
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.